Amicizia Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.17 M
- Revenue Growth 11.63%
- Profit Growth -15.03%
- Ebitda -2.08%
- Net Worth 13.50%
- Total Assets 46.34%
About Amicizia Life Science
Amicizia Life Science Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 June 2015 (Nine years and eight months 19 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.17 M.
Abhijit Ojha and Shamita Ojha serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52100WB2015PTC206602
- Company No.
206602
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2015
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Amicizia Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Ojha  | Director | 05-Jun-2015 | Current |
| Shamita Ojha | Director | 05-Jun-2015 | Current |
Financial Performance of Amicizia Life Science.
Amicizia Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.63% increase. The company also saw a substantial fall in profitability, with a 15.03% decrease in profit. The company's net worth Soared by an impressive increase of 13.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amicizia Life Science?
In 2020, Amicizia Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.17 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.42 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2021 | Others | ₹0.67 M | Open |
| 12 Dec 2018 | Others | ₹3.50 M | Open |
How Many Employees Work at Amicizia Life Science?
Amicizia Life Science has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amicizia Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amicizia Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.